Trials / Completed
CompletedNCT02923258
Postoperative CCRT With Docetaxel vs Cisplatin in High Risk Oral Cavity Cancer
Postoperative Radiation and Concurrent Chemotherapy With Weekly Docetaxel Versus Cisplatin in Patients With High-risk Oral Cavity Cancer: a Randomized Phase II Clinical Trial
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 224 (actual)
- Sponsor
- Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized,controled, phase II, open label study of postoperative concurrent chemoradiotherapy with Docetaxel versus Cisplatin for high-risk squamous cell carcinoma of the oral cavity cancer.The primary purpose of this study is to evaluate the efficacy of concurrent chemoradiotherapy with docetaxel in OCC patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Docetaxel | 20mg/m2/w |
| DRUG | Cisplatin | 100mg/m2/q3w |
| RADIATION | IMRT | a total dose of 60Gy in 30fractions over 6 weeks |
Timeline
- Start date
- 2018-04-21
- Primary completion
- 2022-02-28
- Completion
- 2023-04-30
- First posted
- 2016-10-04
- Last updated
- 2024-06-20
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02923258. Inclusion in this directory is not an endorsement.